Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 24
212
Views
8
CrossRef citations to date
0
Altmetric
Short Communications

Anti-inflammatory effect of methoxyflavonoids from Chiliadenus montanus (Jasonia Montana) growing in Egypt

, , , , &
Pages 5909-5913 | Received 06 May 2020, Accepted 17 Jul 2020, Published online: 04 Aug 2020

References

  • Abdellatif KRA, Fadaly WAA, Kamel GM, Elshaier YAMM, El-Magd MA. 2019. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors. Bioorg Chem. 82:86–99.
  • Al-Howiriny T, Al-Rehaily A, Pols J, Porter J, Mossa J, Ahmed B. 2005. Three new diterpenes and the biological activity of different extracts of Jasonia montana. Nat Prod Res. 19(3):253–265.
  • Chen CY, Peng WH, Tsai KD, Hsu SL. 2007. Luteolin suppresses inflammation-associated gene expression by blocking NF-kappaB and AP-1 activation pathway in mouse alveolar macrophages. Life Sci. 81(23-24):1602–1614.
  • Elgazar AA, Selim NM, Abdel-Hamid NM, El-Magd MA, El Hefnawy HM. 2018. Isolates from Alpinia officinarum Hance attenuate LPS-induced inflammation in HepG2: evidence from in silico and in vitro studies. Phytother Res. 32(7):1273–1288.
  • Garcia-Lafuente A, Guillamo E, Villares A, Rostagno MA, Martınez JA. 2009. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res. 58(9):537–552.
  • Hamed A, Mohamed T, Tawfik W, Hassan E, Higgins M, El-Toumy S, Dinkova-Kostova A. 2016. Bioactive polymethoxylated flavonoids from Chiliadenus montanus. J Chem Pharm Res. 3:788–793.
  • Hussein MA. 2008. Antidiabetic and antioxidant activity of Jasonia montana extract in streptozotocin-induced diabetic rats. Saudi Pharm J. 16:214–221.
  • Hussein MA, Abdel-Gawad SM. 2010. Protective effect of Jasonia montana against ethinylestradiol induced cholestasis in rats. Saudi Pharm J. 18(1):27–45.
  • Medzhitov R. 2008. Origin and physiological roles of inflammation. Nature. 454(7203):428–435.
  • Merxmuller H, Liens P, Roesseler H. 1977. In: Heywood JB, Harborne JB, Turner BL (Eds.). The Biology and Chemistry of Compositae, p. 590. New York: Academic Press.
  • Orlando BJ, Malkowski MG. 2016. Crystal structure of rofecoxib bound to human cyclooxygenase-2. Acta Crystallogr F Struct Biol Commun. 72(Pt 10):772–776.
  • Sanchez-Munoz F, Dominguez-Lopez A, Yamamoto-Furusho JK. 2008. Role of cytokines in inflammatory bowel disease. World J Gastroenterol. 14(27):4280–4288.
  • Selim NM, Elgazar AA, Abdel-Hamid NM, El-Magd MRA, Yasri A, Hefnawy HME, Sobeh M. 2019. Chrysophanol, physcion, hesperidin and curcumin modulate the gene expression of pro-inflammatory mediators induced by LPS in HepG2: in silico and molecular studies. Antioxidants. 8:371.
  • Shapiro H, Singer P, Halpern Z, Bruck R. 2007. Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis. Gut. 56(3):426–436.
  • Tackholm V. 1974. Students flora of Egypt, p. 562. Beirut: Cairo University.
  • Triantafilou M, Triantafilou K. 2005. Invited review: the dynamics of LPS recognition: complex orchestration of multiple receptors. J. Endotoxin Res. 11(1):5–11.
  • Urban MK. 2000. COX-2 specific inhibitors offer improved advantages over traditional NSAIDs. Orthopedics. 23(7 Suppl):S761–S764.
  • Wang JL, Limburg D, Graneto MJ, Springer J, Hamper JR, Liao S, Pawlitz JL, Kurumbail RG, Maziasz T, Talley JJ, et al. 2010. The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: the second clinical candidate having a shorter and favorable human half-life. Bioorg Med Chem Lett. 20(23):7159–7163.,

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.